Maximus (NYSE:MMS) Reaches New 12-Month Low – Here’s Why

Maximus, Inc. (NYSE:MMSGet Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $56.92 and last traded at $59.4150, with a volume of 45899 shares trading hands. The stock had previously closed at $59.90.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on MMS shares. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Check Out Our Latest Research Report on Maximus

Maximus Trading Up 0.3%

The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The firm has a market cap of $3.16 billion, a PE ratio of 8.96 and a beta of 0.60. The stock’s 50 day simple moving average is $66.33 and its 200 day simple moving average is $78.53.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. During the same period in the previous year, the firm posted $2.01 EPS. The firm’s revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 8.4 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, May 15th. Maximus’s payout ratio is currently 19.76%.

Insider Activity

In other news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.80% of the company’s stock.

Institutional Trading of Maximus

Hedge funds have recently made changes to their positions in the stock. Edgestream Partners L.P. purchased a new stake in shares of Maximus in the 1st quarter valued at $4,060,000. Amundi raised its position in Maximus by 117.2% in the 1st quarter. Amundi now owns 5,233 shares of the health services provider’s stock worth $335,000 after purchasing an additional 2,824 shares during the period. California State Teachers Retirement System raised its position in Maximus by 18.8% in the 1st quarter. California State Teachers Retirement System now owns 63,142 shares of the health services provider’s stock worth $4,047,000 after purchasing an additional 9,988 shares during the period. Quantinno Capital Management LP raised its position in Maximus by 413.1% in the 1st quarter. Quantinno Capital Management LP now owns 76,181 shares of the health services provider’s stock worth $4,883,000 after purchasing an additional 61,335 shares during the period. Finally, Rice Hall James & Associates LLC raised its position in Maximus by 4.2% in the 1st quarter. Rice Hall James & Associates LLC now owns 222,924 shares of the health services provider’s stock worth $14,289,000 after purchasing an additional 8,929 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Company Profile

(Get Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Read More

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.